Yes, the PCRI Conference is a community or a village of people coming together to share the latest thoughts and ideas on how to deal with prostate cancer. And this, my friends, provides the ultimate calming effect; not only meeting others like you but also empowering each other with more knowledge and friendships and ultimately more solutions and peace of mind.
Viewing entries tagged
Novel Agent Being Explored in Two Trials of High-Risk Prostate Cancer | An Article by Dr. Berberabe for Cure Magazine
"Researchers are hopeful about the potential for a novel agent in high-risk prostate cancer" states Tony Berberabe, MPh in his published article for Cure Magazine on June 23rd, 2016
Silvia answers Helpline calls, lending a unique and valuable perspective to callers. This article shares some of her experiences with managing both her father’s and mother’s battle with cancer.
Sunnybrook Health Sciences Centre’s Laurence Klotz, MD, speaks with PCRI about management of low-risk prostate cancer with Active Surveillance.
What is active surveillance, and how does it compare with other methods of treating prostate cancer?
The concept of conservative management for prostate cancer is not new. In fact, in Scandinavia and England in the 70s, basically no one was treated until they had metastatic disease. And the idea was that treatment....
We're pleased to announce that we'll be working with KMI on videos for the new SHADES program. Stay tuned for more information on this groundbreaking patient education series.
In the mean, time check out our Prostate Cancer 101 video series below:
LDR (low dose rate) brachytherapy for prostate cancer is more commonly known as seed implants. You may be familiar with this treatment option but for those of you who may be new to the confusing world of prostate cancer treatment, seed implants involve the insertion of small radioactive pellets or seeds into the prostate by transrectal ultrasound guidance, in order to deliver a focused dose of radiation to the prostate.